A nurse is caring for a client who is taking rosuvastatin.
Which of the following findings should the nurse report to the provider immediately?
Dyspepsia.
Elevated creatine kinase.
Headache.
Decreased HDL cholesterol.
The Correct Answer is B
Choice A rationale
Dyspepsia, or indigestion, can occur with statin use but is not usually indicative of a severe adverse reaction. It typically presents as discomfort or pain in the upper abdomen and can often be managed with dietary adjustments or antacids.
Choice B rationale
Elevated creatine kinase levels suggest muscle damage, which may indicate rhabdomyolysis, a serious side effect of statins like rosuvastatin. This condition can lead to kidney damage or failure and requires immediate medical intervention.
Choice C rationale
Headache is a common side effect of many medications, including statins. While uncomfortable, it is generally not considered an emergency unless accompanied by other symptoms such as vision changes or neurological deficits.
Choice D rationale
Decreased HDL cholesterol is not typically an urgent concern in the context of statin therapy. Rosuvastatin is prescribed to lower LDL cholesterol and reduce cardiovascular risk, with less emphasis on HDL cholesterol levels. .
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale
Granisetron is a serotonin antagonist used to prevent nausea and vomiting, common adverse effects of topotecan, an anticancer drug that targets DNA synthesis.
Choice B rationale
Insulin lispro is a rapid-acting insulin used to manage blood glucose levels in diabetic patients, not to treat the adverse effects of topotecan.
Choice C rationale
Docusate sodium is a stool softener used to treat constipation, which is not typically an adverse effect of topotecan. Nausea and vomiting are more common.
Choice D rationale
Prednisone is a corticosteroid used to reduce inflammation and suppress the immune system, but it is not typically used to treat nausea or vomiting caused by topotecan.
Correct Answer is C
Explanation
Choice A rationale
Sargramostim stimulates white blood cell production, particularly granulocytes and macrophages. It is used for neutropenia, not anemia, as it does not target red blood cells or hemoglobin levels.
Choice B rationale
Filgrastim also stimulates white blood cell production, specifically neutrophils. It is used to treat neutropenia but does not address the red blood cell deficiency in anemia.
Choice C rationale
Epoetin stimulates red blood cell production in the bone marrow by mimicking erythropoietin. It is commonly used to treat anemia, especially in patients undergoing chemotherapy.
Choice D rationale
Romiplostim stimulates platelet production by activating the thrombopoietin receptor. It is used for thrombocytopenia but does not help increase red blood cells in anemia. .
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.